Sandbox/table: Difference between revisions
< Sandbox
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{| | The following table contains the main risk factors for CDI:<ref name="pmid22146873">{{cite journal| author=Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ| title=Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. | journal=J Antimicrob Chemother | year= 2012 | volume= 67 | issue= 3 | pages= 742-8 | pmid=22146873 | doi=10.1093/jac/dkr508 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22146873 }} </ref><ref name="KnightSurawicz2013">{{cite journal|last1=Knight|first1=Christopher L.|last2=Surawicz|first2=Christina M.|title=Clostridium difficile Infection|journal=Medical Clinics of North America|volume=97|issue=4|year=2013|pages=523–536|issn=00257125|doi=10.1016/j.mcna.2013.02.003}}</ref><ref name="Planche2013">{{cite journal|last1=Planche|first1=Tim|title=Clostridium difficile|journal=Medicine|volume=41|issue=11|year=2013|pages=654–657|issn=13573039|doi=10.1016/j.mpmed.2013.08.003}}</ref><ref name="KnightSurawicz2013">{{cite journal|last1=Knight|first1=Christopher L.|last2=Surawicz|first2=Christina M.|title=Clostridium difficile Infection|journal=Medical Clinics of North America|volume=97|issue=4|year=2013|pages=523–536|issn=00257125|doi=10.1016/j.mcna.2013.02.003}}</ref><ref name="KnightSurawicz2013">{{cite journal|last1=Knight|first1=Christopher L.|last2=Surawicz|first2=Christina M.|title=Clostridium difficile Infection|journal=Medical Clinics of North America|volume=97|issue=4|year=2013|pages=523–536|issn=00257125|doi=10.1016/j.mcna.2013.02.003}}</ref> | ||
| | |||
< | |||
< | |||
</ | |||
</ | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
! style="width: 500px;background: #4479BA"|{{fontcolor|#FFF| '''''Severity of the disease'''''}} | |||
|- | |- | ||
| style=" | | style="width: 120px;background: #F5F5F5"| Mild: diarrhea as the only symptom | ||
|- | |- | ||
| style=" | | style="width: 120px;background: #DCDCDC"| Moderate: raised white cell count but <15,000 cells/mL and serum creatine <1.5 times baseline | ||
|- | |- | ||
| style=" | | style="width: 120px;background: #F5F5F5"| Severe: leucocytosis >15,000 cells/mL OR serum creatinene level >1.5 times baseline or abdominal tenderness and serum albumin < 3 g/dL | ||
|- | |- | ||
| style=" | | style="width: 120px;background: #DCDCDC"| Severe complicated: hypotension or shock, ileus, megacolon, leucocytosis >20,000 cells/mL OR leucopenia <2,000, lactate >2.2 mmol/L, delirium, fever ≥ 38.5 °C, organ failure | ||
|- | |- | ||
| style=" | |} | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align=center | |||
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Community-onset infection '''''}} | |||
! style="width: 300px;background: #4479BA"|{{fontcolor|#FFF| '''''Hospital-onset infection '''''}} | |||
|- | |- | ||
| style=" | | style="width: 120px;background: #F5F5F5"| Includes patients with 1 or more of the following conditions: | ||
*The presence of an invasive device at time of admission | |||
*History of [[MRSA]] infection or colonization | |||
*History of surgery, hospitalization, [[dialysis]], or residence in a long-term care facility in the previous 12 months. | |||
| style="width: 120px;background: #F5F5F5"| Includes patients with positive culture results obtained >48 h after admission. <br> Patients might also have 1 of the conditions described in community-onset infection. | |||
|- | |- | ||
|} | |} | ||
Revision as of 17:25, 16 June 2014
The following table contains the main risk factors for CDI:[1][2][3][2][2]
| Severity of the disease |
|---|
| Mild: diarrhea as the only symptom |
| Moderate: raised white cell count but <15,000 cells/mL and serum creatine <1.5 times baseline |
| Severe: leucocytosis >15,000 cells/mL OR serum creatinene level >1.5 times baseline or abdominal tenderness and serum albumin < 3 g/dL |
| Severe complicated: hypotension or shock, ileus, megacolon, leucocytosis >20,000 cells/mL OR leucopenia <2,000, lactate >2.2 mmol/L, delirium, fever ≥ 38.5 °C, organ failure |
| Community-onset infection | Hospital-onset infection |
|---|---|
| Includes patients with 1 or more of the following conditions: | Includes patients with positive culture results obtained >48 h after admission. Patients might also have 1 of the conditions described in community-onset infection. |
- ↑ Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012). "Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics". J Antimicrob Chemother. 67 (3): 742–8. doi:10.1093/jac/dkr508. PMID 22146873.
- ↑ 2.0 2.1 2.2 Knight, Christopher L.; Surawicz, Christina M. (2013). "Clostridium difficile Infection". Medical Clinics of North America. 97 (4): 523–536. doi:10.1016/j.mcna.2013.02.003. ISSN 0025-7125.
- ↑ Planche, Tim (2013). "Clostridium difficile". Medicine. 41 (11): 654–657. doi:10.1016/j.mpmed.2013.08.003. ISSN 1357-3039.